Hansoh Pharma Strikes Roche Drug Deal Worth Over $15 Billion
Hansoh Pharmaceutical said its units entered a collaboration and licensing deal with Roche covering antibody-drug conjugate programs. The deal is potentially worth more than $15 billion.
China's Hansoh Pharmaceutical HKEX:3692 said on Monday its units have entered into a collaboration and licensing deal with Roche BX:RHO potentially worth more than $15 billion, covering a portfolio of antibody-drug conjugate programs.Under the deal, Hansoh will receive an upfront payment of $400 mi…